Active	Status	Sponsor type	Region	Phase	Filter
9 Active 56 Inactive 65 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Newby, David E
DUAL-ACS2 , NCT03252249: Duration of Dual Anti-Platelet Therapy (DUAL-ACS)	Completed	4	4576	Europe	3 months dual anti-platelet therapy, 12 months dual anti-platelet therapy	University of Edinburgh, British Heart Foundation	Acute Coronary Syndrome, Coronary Artery Disease	02/23	02/23
FRONTIER, NCT05085275: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease	Completed	3	289	US	Ferric Citrate 1 GM Oral Tablet [AURYXIA], Auryxia, Placebo	USRC Kidney Research, Akebia Therapeutics	Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron	01/24	01/24
MEMORY, NCT04623788: Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) in Ischaemic, Inflammatory and Takotsubo Cardiomyopathy	Completed	N/A	51	Europe	Cardiac MRI	University of Edinburgh	Myocarditis, Takotsubo Cardiomyopathy, Reversible Coronary Ischaemia	06/23	06/23
AC19113, NCT04156061: Effect of the SCOT-HEART 2 Trial on Lifestyle.	Recruiting	N/A	400	Europe	Delivery of CT scan results	University of Edinburgh, British Heart Foundation, NHS Lothian	Coronary Artery Disease, Primary Prevention	01/24	07/27
SCOT-HEART 2, NCT03920176: Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (The Trial)	Recruiting	N/A	6000	Europe	Computed tomography coronary angiography, ASSIGN Score	University of Edinburgh, British Heart Foundation, NHS Lothian	Cardiovascular Diseases	12/25	12/28
PERFECT, NCT06521047: A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial	Recruiting	N/A	48	Europe	NA - Observational study	CellProthera	Acute Myocardial Infarction	03/34	03/34
NCT06113510: Non-invasive Coronary Thrombus Imaging to Define These Cause of Acute Myocardial Infarction	Not yet recruiting	N/A	80	Europe	Hybrid 18F-GP1 positron emission tomography and coronary computed tomography coronary angiography	University of Edinburgh	Myocardial Infarction, Thrombosis	08/26	08/27
Dhaliwal, Kev
DEFINE, NCT04473053: - Evaluating Therapies for COVID-19	Recruiting	1/2	200	Europe	Nafamostat Mesilate, TD139, Standard care, Allogeneic SARS-CoV-2 VSTs	University of Edinburgh, University of Oxford, Latus Therapeutics, Scottish National Blood Transfusion Service (SNBTS)	COVID-19	04/25	04/25
DUAL, NCT02676050: Visualising c-MET and Activated Neutrophils in Lung Cancer	Terminated	1	5	Europe	Optical Imaging Agents (EMI-137, NAP), EMI-137, NAP, Delivery Device Cathetar and Miniaturised imaging fibre, Optical endomicroscopy system	University of Edinburgh, NHS Lothian	Lung Cancer	12/21	03/22
Haslett, Chris
No trials found
Walsh, Tim
No trials found